✦ LIBER ✦

Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies

✍ Scribed by P. C. WONG; E. J. CRAIN; B. XIN; R. R. WEXLER; P. Y. S. LAM; D. J. PINTO; J. M. LUETTGEN; R. M. KNABB

Book ID: 109152497
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 371 KB
Volume: 6
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2008.02939.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chromogenic laboratory assays to measure

Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor

✍ Richard C. Becker; Hongqiu Yang; Yuchen Barrett; Puneet Mohan; Jessie Wang; Lars 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 374 KB

In vitro and in vivo studies of the nove

In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct Factor Xa inhibitor

✍ E. PERZBORN; J. STRASSBURGER; A. WILMEN; J. POHLMANN; S. ROEHRIG; K-H. SCHLEMMER 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

The syntheses and in vitro biotransforma

The syntheses and in vitro biotransformation studies of [14C]apixaban, a highly potent, selective, efficacious and orally bioavailable inhibitor of blood coagulation Factor Xa

✍ Brad D. Maxwell; Scott B. Tran; Shiang-Yuan Chen; Donglu Zhang; Bang-Chi Chen; H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 223 KB 👁 1 views

## Abstract Apixaban is a potent inhibitor of blood coagulation Factor Xa in the late stages of development. [^14^C]apixaban was synthesized with the 14C label in the two different lactam ring systems within the molecule for various __in vitro__ and __in vivo__ metabolism studies. A nine‐step synth

Arterial antithrombotic and bleeding tim

Arterial antithrombotic and bleeding time effects of apixaban, a direct factor Xa inhibitor, in combination with antiplatelet therapy in rabbits

✍ P. C. WONG; C. A. WATSON; E. J. CRAIN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

The efficacy and safety of apixaban, an

The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement

✍ M. R. LASSEN; B. L. DAVIDSON; A. GALLUS; G. PINEO; J. ANSELL; D. DEITCHMAN 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

In vitro inhibition of thrombin generati

In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban

✍ G. T. GEROTZIAFAS; I. ELALAMY; F. DEPASSE; E. PERZBORN; M. M. SAMAMA 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB